| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Stuelpnagel John R is a Director at 10x Genomics, Inc.. Recent SEC Form 4 filings include 0 buys and 71 sells.
Estimated insider holdings value: $7.8M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 2, 2021 | TXG 10x Genomics, Inc. | Director | Sell | 5,000 | $180.42 | $902,101.98 | -0.2% | -8.2% | -77.1% | |
| Jul 16, 2021 | TXG 10x Genomics, Inc. | Director | Sell | 5,000 | $170.31 | $851,528.63 | -0.3% | -10.2% | -79.0% | |
| Jul 1, 2021 | TXG 10x Genomics, Inc. | Director | Sell | 3,900 | $192.68 | $751,449.73 | -0.2% | -23.2% | -75.3% | |
| Jun 17, 2021 | TXG 10x Genomics, Inc. | Director | Sell | 5,000 | $199.38 | $996,920.90 | -0.1% | -21.4% | -80.7% | |
| Jun 1, 2021 | TXG 10x Genomics, Inc. | Director | Sell | 7,500 | $174.49 | $1,308,664.61 | -0.2% | -1.4% | -73.8% | |
| May 17, 2021 | TXG 10x Genomics, Inc. | Director | Sell | 7,500 | $141.57 | $1,061,740.29 | -0.3% | +11.3% | -65.6% | |
| May 3, 2021 | TXG 10x Genomics, Inc. | Director | Sell | 7,500 | $191.81 | $1,438,550.55 | -0.3% | -7.4% | -73.7% | |
| Apr 16, 2021 | TXG 10x Genomics, Inc. | Director | Sell | 7,500 | $192.61 | $1,444,542.66 | -0.2% | -12.4% | -68.0% | |
| Apr 1, 2021 | TXG 10x Genomics, Inc. | Director | Sell | 7,500 | $184.53 | $1,383,969.27 | -0.3% | +5.4% | -56.3% | |
| Mar 17, 2021 | TXG 10x Genomics, Inc. | Director | Sell | 7,500 | $169.36 | $1,270,181.29 | -0.2% | +11.8% | -60.6% |